These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 385986)

  • 41. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
    Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
    J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.
    Huang JK; Bartsch W; Voigt KD
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):569-76. PubMed ID: 2930988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New observation on androgen action: androgen receptor stabilization and antisteroid effects of LHRH agonists.
    Wright W; Chan K; Sundaram K; Bardin CW
    Adv Exp Med Biol; 1981; 138():325-36. PubMed ID: 7044055
    [No Abstract]   [Full Text] [Related]  

  • 44. Evidence that inhibited prostatic epithelial bud formation in 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed C57BL/6J fetal mice is not due to interruption of androgen signaling in the urogenital sinus.
    Ko K; Theobald HM; Moore RW; Peterson RE
    Toxicol Sci; 2004 Jun; 79(2):360-9. PubMed ID: 15056816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R 1881 binding to the prostatic androgen receptor and [3H]5 alpha-dihydrotestosterone and [3H]cortisol binding to plasma proteins.
    Ayub M; Levell MJ
    J Steroid Biochem; 1989 Aug; 33(2):251-5. PubMed ID: 2788775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen receptors in the diabetic rat.
    Tesone M; Oliveira-Filho RM; Valle LB; Calvo JC; Barañao JL; Foglia VG; Charreau EH
    Diabetologia; 1980 May; 18(5):385-90. PubMed ID: 6968699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Androgen receptors and the molecular basis for the action of antiadrogens in the ventral prostate.
    Tymoczko JL; Liao S
    J Reprod Fertil Suppl; 1976 Sep; (24 suppl):147-62. PubMed ID: 794465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Marihuana inhibits dihydrotestosterone binding to the androgen receptor.
    Purohit V; Ahluwahlia BS; Vigersky RA
    Endocrinology; 1980 Sep; 107(3):848-50. PubMed ID: 6249575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Androgens regulate brain aromatase activity in adult male rats through a receptor mechanism.
    Roselli CE; Resko JA
    Endocrinology; 1984 Jun; 114(6):2183-9. PubMed ID: 6723579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of aging on androgen dynamics in the male rat.
    Robinette CL; Mawhinney MG
    Arch Biochem Biophys; 1978 Dec; 191(2):503-16. PubMed ID: 742886
    [No Abstract]   [Full Text] [Related]  

  • 51. Androgen receptor protein in the androgen-dependent Dunning R-3327 prostate carcinoma.
    Lea OA; French FS
    Cancer Res; 1981 Feb; 41(2):619-23. PubMed ID: 7448809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antagonist action of dihydroprogesterone on the formation of the specific dihydrotestosterone-cytoplasmic receptor complex in rat ventral prostate.
    Wright F; Kirchhoffer MO; Mauvais-Jarvis P
    J Steroid Biochem; 1979 Apr; 10(4):419-22. PubMed ID: 449318
    [No Abstract]   [Full Text] [Related]  

  • 53. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
    Fenton MA; Shuster TD; Fertig AM; Taplin ME; Kolvenbag G; Bubley GJ; Balk SP
    Clin Cancer Res; 1997 Aug; 3(8):1383-8. PubMed ID: 9815822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of mutant androgen receptors by flutamide.
    Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
    Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
    Furr BJ
    Prog Clin Biol Res; 1988; 260():13-26. PubMed ID: 2966405
    [No Abstract]   [Full Text] [Related]  

  • 57. Androgen receptor dependent and independent activities of testosterone on hepatic microsomal drug metabolism.
    Brown TR; Greene FE; Bardin CW
    Endocrinology; 1976 Nov; 99(5):1353-62. PubMed ID: 991826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of gestonorone caproate on rat prostate.
    Hayashi T; Glotz HJ; Aono T; Matsumoto K
    J Steroid Biochem; 1979 Sep; 11(3):1217-21. PubMed ID: 513741
    [No Abstract]   [Full Text] [Related]  

  • 59. Nonsteroidal compounds which bind epididymal androgen-binding protein but not the androgen receptor.
    Rousseau GG; Quivy JI; Kirchhoff J; Bui XH; Devis R
    Nature; 1980 Apr; 284(5755):458-9. PubMed ID: 6965770
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effects of antiprostatic agents on the accessory sex organs of rats treated with adrenal androgens].
    Imai K; Takahashi O; Watanabe K; Nakazawa Y; Nakata S; Yamanaka H
    Hinyokika Kiyo; 1991 Dec; 37(12):1669-76. PubMed ID: 1785391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.